Overall, our results revealed a novel mechanism of miR-122-5p activating transcription of IGFBP4 and highlighted the clinical value of miR-122-5p and IGFBP4 in inhibiting ICC invasion and metastasis (Fig. 7a). The gene discussed is IGFBP4; the disease is intrahepatic cholangiocarcinoma.